Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Linecker

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Surgery|January 14, 2017
Neoadjuvant chemotherapy does not affect future liver remnant growth and outcomes of associating liver partition and portal vein ligation for staged hepatectomyKristina Hasselgren, Massimo Malagò, Soumil Vyas, et al.
FASEB Bioadvances|February 12, 2019
Yes-associated protein promotes early hepatocyte cell cycle progression in regenerating liver after tissue lossChristoph Tschuor, Ekaterina Kachaylo, Udo Ungethüm, et al.
Annals of Surgery|July 19, 2023
Early Postoperative Serum Phosphate Drop Predicts Sufficient Hypertrophy After Liver SurgeryPatryk Kambakamba, Marcel A Schneider, Michael Linecker, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 21, 2019
Renal Impairment Is Associated with Reduced Outcome After Associating Liver Partition and Portal Vein Ligation for Staged HepatectomyTim Reese, Mohammad H Fard-Aghaie, Georgios Makridis, et al.
Science Translational Medicine|September 15, 2021
Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor modelsMarcel André Schneider, Laura Heeb, Michal Mateusz Beffinger, et al.
BMC Cancer|October 21, 2016
Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trialPerparim Limani, Michael Linecker, Philipp Kron, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 21, 2023
Normalization of lipid oxidation defects arising from hypoxia early posthepatectomy prevents liver failure in mouseDominique Lisa Birrer, Ekaterina Kachaylo, Eva Breuer, et al.
Nature Communications|June 22, 2021
Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumorsMarcel A Schneider, Michael Linecker, Ralph Fritsch, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 17, 2021
Repeated hepatectomy after ALPPS for recurrence of colorectal liver metastasis: the edge of limits?Tim Reese, Georgios Makridis, Dimitri Raptis, et al.
Surgery|November 6, 2016
How much liver needs to be transected in ALPPS? A translational study investigating the concept of less invasivenessMichael Linecker, Patryk Kambakamba, Cäcilia S Reiner, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Surgery|January 14, 2017
Neoadjuvant chemotherapy does not affect future liver remnant growth and outcomes of associating liver partition and portal vein ligation for staged hepatectomyKristina Hasselgren, Massimo Malagò, Soumil Vyas, et al.
FASEB Bioadvances|February 12, 2019
Yes-associated protein promotes early hepatocyte cell cycle progression in regenerating liver after tissue lossChristoph Tschuor, Ekaterina Kachaylo, Udo Ungethüm, et al.
Annals of Surgery|July 19, 2023
Early Postoperative Serum Phosphate Drop Predicts Sufficient Hypertrophy After Liver SurgeryPatryk Kambakamba, Marcel A Schneider, Michael Linecker, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 21, 2019
Renal Impairment Is Associated with Reduced Outcome After Associating Liver Partition and Portal Vein Ligation for Staged HepatectomyTim Reese, Mohammad H Fard-Aghaie, Georgios Makridis, et al.
Science Translational Medicine|September 15, 2021
Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor modelsMarcel André Schneider, Laura Heeb, Michal Mateusz Beffinger, et al.
BMC Cancer|October 21, 2016
Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trialPerparim Limani, Michael Linecker, Philipp Kron, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 21, 2023
Normalization of lipid oxidation defects arising from hypoxia early posthepatectomy prevents liver failure in mouseDominique Lisa Birrer, Ekaterina Kachaylo, Eva Breuer, et al.
Nature Communications|June 22, 2021
Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumorsMarcel A Schneider, Michael Linecker, Ralph Fritsch, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 17, 2021
Repeated hepatectomy after ALPPS for recurrence of colorectal liver metastasis: the edge of limits?Tim Reese, Georgios Makridis, Dimitri Raptis, et al.
Surgery|November 6, 2016
How much liver needs to be transected in ALPPS? A translational study investigating the concept of less invasivenessMichael Linecker, Patryk Kambakamba, Cäcilia S Reiner, et al.
Pageof 7